L’Oréal Sunscreen Promo Burns Reputation Of Competing Products – Suit
This article was originally published in The Rose Sheet
Executive Summary
Promotional material for L'Oréal's La Roche-Posay Anthelios SX sunscreen moisturizer makes false statements that disparage competing sunscreen products,according to a lawsuit filed by Johnson & Johnson's Neutrogena Corporation and J&J Consumer Companies, Inc
You may also be interested in...
FDA approves Anthelios 40 sunscreen
La Roche-Posay announces FDA approval of Anthelios 40 sunscreen, which contains "highest photostable UVA and UVB protection available in a sunscreen with Mexoryl SX," according to April 18 release. Product contains "unique, synergistic" combination of sun filters, and has been specifically tested for safety on individuals with photosensitive skin disorder, Polymorphous Light Eruption (PMLE). L'Oréal division notes that "up to 17% of the U.S. population alone experience symptoms related to PMLE as a result of UV (primarily UVA) exposure." Firm's Memoryl SX filter is touted as being uniquely photostable compared with other UVA protectants (1"The Rose Sheet" July 31, 2006, p. 3). Slated to launch in late spring, the sunscreen costs $29.50. Other Anthelios products include Anthelios SX Daily Moisturizing Cream with SPF 15 and Anthelios 15 Water Resistant Sunscreen Cream. Johnson & Johnson filed suit against L'Oréal in October 2006 charging the firm with false advertising and unfair competition, based on statements made in promotional materials for Anthelios SX (2"The Rose Sheet" Oct. 16, 2006, p. 5)...
FDA approves Anthelios 40 sunscreen
La Roche-Posay announces FDA approval of Anthelios 40 sunscreen, which contains "highest photostable UVA and UVB protection available in a sunscreen with Mexoryl SX," according to April 18 release. Product contains "unique, synergistic" combination of sun filters, and has been specifically tested for safety on individuals with photosensitive skin disorder, Polymorphous Light Eruption (PMLE). L'Oréal division notes that "up to 17% of the U.S. population alone experience symptoms related to PMLE as a result of UV (primarily UVA) exposure." Firm's Memoryl SX filter is touted as being uniquely photostable compared with other UVA protectants (1"The Rose Sheet" July 31, 2006, p. 3). Slated to launch in late spring, the sunscreen costs $29.50. Other Anthelios products include Anthelios SX Daily Moisturizing Cream with SPF 15 and Anthelios 15 Water Resistant Sunscreen Cream. Johnson & Johnson filed suit against L'Oréal in October 2006 charging the firm with false advertising and unfair competition, based on statements made in promotional materials for Anthelios SX (2"The Rose Sheet" Oct. 16, 2006, p. 5)...
L’Oréal’s Anthelios SX Will Launch Following FDA Approval Of UVA Filter
L'Oréal will introduce Anthelios SX, the first product on the U.S. market containing a sun filter for short UVA wave protection this fall, the company announced July 24